CARBIOS (ALCRB.PA) Stock Fundamental Analysis
EPA:ALCRB - Euronext Paris - Matif - FR0011648716 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to ALCRB. ALCRB was compared to 66 industry peers in the Chemicals industry. While ALCRB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALCRB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ALCRB had negative earnings in the past year.
In the past year ALCRB has reported a negative cash flow from operations.
In the past 5 years ALCRB reported 4 times negative net income.
ALCRB had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALCRB's Return On Assets of -11.21% is on the low side compared to the rest of the industry. ALCRB is outperformed by 78.79% of its industry peers.
ALCRB has a Return On Equity of -14.55%. This is in the lower half of the industry: ALCRB underperforms 75.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.21% | ||
| ROE | -14.55% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for ALCRB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALCRB does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ALCRB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of 1.02, we must say that ALCRB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.02, ALCRB is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.17 indicates that ALCRB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.17, ALCRB is doing good in the industry, outperforming 78.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.02 |
ROIC/WACCN/A
WACC7.36%
2.3 Liquidity
ALCRB has a Current Ratio of 7.52. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALCRB (7.52) is better than 96.97% of its industry peers.
A Quick Ratio of 7.45 indicates that ALCRB has no problem at all paying its short term obligations.
The Quick ratio of ALCRB (7.45) is better than 98.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.52 | ||
| Quick Ratio | 7.45 |
3. Growth
3.1 Past
The earnings per share for ALCRB have decreased by -0.29% in the last year.
ALCRB shows a strong growth in Revenue. In the last year, the Revenue has grown by 466.67%.
The Revenue for ALCRB have been decreasing by -37.71% on average. This is quite bad
EPS 1Y (TTM)-0.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)466.67%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%1475%
3.2 Future
ALCRB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.01% yearly.
Based on estimates for the next years, ALCRB will show a very strong growth in Revenue. The Revenue will grow by 300.17% on average per year.
EPS Next Y1.82%
EPS Next 2Y8.12%
EPS Next 3Y6.49%
EPS Next 5Y27.01%
Revenue Next Year3724.84%
Revenue Next 2Y1099.31%
Revenue Next 3Y509.81%
Revenue Next 5Y300.17%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALCRB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCRB. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.12%
EPS Next 3Y6.49%
5. Dividend
5.1 Amount
No dividends for ALCRB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALCRB (5/30/2025, 7:00:00 PM)
7.745
-0.32 (-3.97%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners23.25%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap130.50M
Analysts83.64
Price Target11.9 (53.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-28.57%
PT rev (3m)-44.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1694.85 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.6 | ||
| P/tB | 0.74 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.97
EYN/A
EPS(NY)-2.22
Fwd EYN/A
FCF(TTM)-3.95
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS0
BVpS12.91
TBVpS10.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.21% | ||
| ROE | -14.55% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 562.84% | ||
| Cap/Sales | 53228.6% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.52 | ||
| Quick Ratio | 7.45 | ||
| Altman-Z | 1.02 |
F-Score2
WACC7.36%
ROIC/WACCN/A
Cap/Depr(3y)437.01%
Cap/Depr(5y)449.88%
Cap/Sales(3y)53289.6%
Cap/Sales(5y)34828.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y1.82%
EPS Next 2Y8.12%
EPS Next 3Y6.49%
EPS Next 5Y27.01%
Revenue 1Y (TTM)466.67%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%1475%
Revenue Next Year3724.84%
Revenue Next 2Y1099.31%
Revenue Next 3Y509.81%
Revenue Next 5Y300.17%
EBIT growth 1Y-27.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.5%
EBIT Next 3Y20.82%
EBIT Next 5Y34.22%
FCF growth 1Y-58.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.7%
OCF growth 3YN/A
OCF growth 5YN/A